bostonscientific.com - BSX Total Company Value-to-Revenue Ratio

Boston Scientific Corp (BSX) - corporate logo

Boston Scientific's dependence on Asian electronics drives its business dynamics, as confirmed by the company's current price-to-sales ratio on the GURU.Markets chart, where this metric stands at 3504.76. While the high precision of robotic lines minimizes product defects, regulatory barriers and government pricing pressure create certain risks for the asset's long-term price growth.

Boston Scientific Inc (BSX) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for Boston Scientific Inc (BSX)

- share price and consensus valuation forecast:
Fundamental company valuation:BSX, bostonscientific.com
Flagship merchandise of Boston Scientific Corp

This metric reflects the Enterprise Value of the entire business relative to annual revenue, excluding the impact of debt load on the valuation. By analyzing the EV/Sales ratio, an investor determines the market premium paid per unit of sales and assesses the efficiency of asset capitalization. The metric's sensitivity to FDA regulatory risks and pressure from insurers makes it a key indicator of the valuation resilience of Boston Scientific (BSX) amid changing operating conditions.

Competitor analysis

Total Company Value-to-Revenue Ratio Edwards Lifesciences EW|RMD: EV/Sales Multiple|Company Value to Revenue Ratio PODD|ZBH (Zimmer) - EV/Sales Multiple|Company Value to Revenue CooperVision (COO)|EV/Sales Multiple ALGN|Company Value to Revenue Globus Medical, Inc. GMED|EV/Sales Multiple TMDX (transmedics.com)|EV/Sales Multiple Alphatec Holdings ATEC|AORT - Enterprise Value-to-Revenue Ratio|ENOV: Enterprise Value-to-Revenue Ratio|IART (Integra LifeSciences) - Company Value to Revenue|Establishment Labs - Business Value to Revenue|BBNX (iLet Bionic Pancreas) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple IRADIMED Corp IRMD|Enterprise Value-to-Revenue Ratio Embecta Corp (EMBC)|Tandem Diabetes Care (TNDM) - Enterprise Value-to-Sales Ratio|Axogen Surgical - Company Value to Revenue|EV/Sales Multiple SI-BONE, Inc. SIBN|Orthofix Medical - EV/Sales Multiple|Enterprise Value to Sales Volume BVS|OrthoPediatrics (KIDS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume TMCI (Treace Corp)|Enterprise Value-to-Revenue Ratio blade.com|Company Value to Revenue Carlsmed Inc (CARL)|EV/Sales Multiple RXST|CLPT - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Stereotaxis, Inc. STXS|STIM: Company Value to Revenue Ratio|SGHT: Company Value to Revenue|Orchestra BioMed Inc. - Enterprise Value-to-Revenue Coefficient|ANIK: EV/Sales Multiple|NSPR - Total Company Value-to-Revenue Ratio|ZJYL (Jin Medical) - EV/Sales Multiple|Vivani Medical (VANI) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple XTNT|EV/Sales Multiple n1mtc.com (NMTC)|Modular Medical Inc - Company Value to Revenue|Myomo, Inc (MYO) - Enterprise Value-to-Revenue Multiple|COCH: Company Value to Revenue|Total Company Value-to-Revenue Ratio Vivos Therapeutics VVOS|enVVeno Medical Corp. (NVNO) - Enterprise Value-to-Revenue Ratio|Sintx Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Tenon Medical Inc.|LFWD: Business Value to Revenue|EV/Sales Multiple AMIX|Enterprise Value-to-Revenue Coefficient IVF|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio